UNLOXCYT (cosibelimab-ipdl) is indicated for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC ...

Now that November is behind us, let’s reflect on the important lessons from CISA’s Critical Infrastructure Security and ...